Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Meheli Chatterjee"'
Autor:
Sandip Ganguly, Joydeep Ghosh, Anisha Gehani, Archisman Basu, Meheli Chatterjee, Deepak Dabkara, Bivas Biswas
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 4, Iss 1, Pp 50-54 (2021)
Background: The majority of all lung cancers are non-small-cell lung cancers (NSCLCs). They usually spread to the pleura, brain, adrenal gland, lungs, liver, and bones. However, clinical data for NSCLC metastasizing to unusual sites are sparse in the
Externí odkaz:
https://doaj.org/article/05b4a38ea2784c7a9969d391d9419d8c
Autor:
Archisman Basu, Meheli Chatterjee, Joydeep Ghosh, Sandip Ganguly, Bivas Biswas, Deepak Dabkara
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 3, Iss 3, Pp 619-621 (2020)
Externí odkaz:
https://doaj.org/article/2cfdd64210ac411d8e6041fe5c65dcae
Autor:
Archisman Basu, Meheli Chatterjee, Deepak Dabkara, Bivas Biswas, Sandip Ganguly, Joydeep Ghosh, Priya Ghosh
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 3, Iss 4, Pp 836-837 (2020)
Externí odkaz:
https://doaj.org/article/a1cfcbc540ff45aa9298051d5c3994b0
Autor:
Meheli Chatterjee, Bivas Biswas, Deepak Dabkara, Sandip Ganguly, Anisha Gehani, Joydeep Ghosh, Archisman Basu
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 4, Iss 1, Pp 50-54 (2021)
Background: The majority of all lung cancers are non-small-cell lung cancers (NSCLCs). They usually spread to the pleura, brain, adrenal gland, lungs, liver, and bones. However, clinical data for NSCLC metastasizing to unusual sites are sparse in the
Autor:
Divya Midha, Archisman Basu, Indranil Mallick, Sumit Mukherjee, Sujoy Gupta, Ammara Hasan, Deepak Dabkara, Joydeep Ghosh, Bivas Biswas, Sandip Ganguly, Satyadip Mukherjee, Meheli Chatterjee
Publikováno v:
The National medical journal of India. 34(2)
Background. Seminomatous germ cell tumour (SGCT) is a rare but curable malignancy of young adults. The literature on management and outcome of SGCT is scarce from India. We report the demography and treatment outcome of SGCT at our centre. Methods. W
Autor:
Basumita Chakraborti, Sonia Mathai, Deepak Dabkara, Archisman Basu, Meheli Chatterjee, Sumedha Gargy, Sandip Ganguly, Arunava Roy, Shweta Rai, Bivas Biswas, Anik Ghosh, Joydeep Ghosh, Jaydip Bhaumik
Publikováno v:
ecancermedicalscience
Background Ovarian germ cell tumours constitute a heterogeneous group of neoplasm with malignant potential being seen in 5% of cases. There is limited data on treatment outcomes of patients with malignant ovarian germ cell tumours (MOGCT). Here, we p
Autor:
Arnab Mukherjee, Soumitra Shankar Datta, Soumita Ghose, Chitralekha Bhowmick, Archisman Basu, Shrestha Chattopadhyay, Surya Bhattacharjee, Meheli Chatterjee
Publikováno v:
ecancermedicalscience
Background Addressing the mental health needs of cancer patients and their caregivers improves the quality of care the patient receives in any cancer care ecosystem. International practice currently encourages integrated care for physical and mental
Autor:
Meheli Chatterjee, Sanjoy Chatterjee, Sandip Ganguly, Bivas Biswas, Sanjit Agarwal, Deepak Dabkara, Joydeep Ghosh, Geetashree Mukherjee, Rosina Ahmed, Anupurva Datta
Publikováno v:
ecancermedicalscience
Purpose Triple-negative breast cancer (TNBC) has a poor outcome compared to other subtypes, even in those with early disease. Immune checkpoint inhibitors (ICIs) have been approved in metastatic diseases and are being tested as a neoadjuvant strategy
Autor:
Meheli Chatterjee, Sandip Ganguly, Archisman Basu, Sujoy Gupta, Satyadip Mukherjee, Deepak Dabkara, Saugata Sen, Bivas Biswas, Joydeep Ghosh
Publikováno v:
ecancermedicalscience
Non-seminomatous germ cell tumour (NSGCT) is a rare but highly curable malignancy. The literature on the management and outcomes of NSGCT is scarce from India. Here, we report the demography and treatment outcomes of NSGCT treated at our centre. This
Publikováno v:
ecancermedicalscience
Background Neuroendocrine carcinoma of the gallbladder (NECGB) is a rare pathological entity. They are found to be aggressive cancers. Treatment strategies are based largely on extrapolation from other small cell cancers. Survival is poor compared to